Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,335 | 18 | 76.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,650 | 2 | 11.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $950.00 | 1 | 6.4% |
| Travel and Lodging | $886.46 | 3 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $14,821 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,486 | 6 | NOVARTIS PHARMACEUTICALS CORPORATION ($3,486) |
| 2022 | $1,787 | 4 | Novartis Pharmaceuticals Corporation ($1,787) |
| 2021 | $2,165 | 4 | Novartis Pharmaceuticals Corporation ($2,165) |
| 2018 | $6,433 | 9 | Novartis Pharmaceuticals Corporation ($6,433) |
| 2017 | $950.00 | 1 | Novartis Pharmaceuticals Corporation ($950.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 11/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 11/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $239.08 | General |
| Category: Neurology | ||||||
| 06/19/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Neurology | ||||||
| 06/19/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $500.00 | General |
| Category: Neurology | ||||||
| 06/19/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $147.38 | General |
| Category: Neurology | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $219.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $117.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $114.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $144.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $144.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $144.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 380 | 408 | $563,532 | $35,451 |
| 2022 | 5 | 424 | 452 | $581,889 | $42,076 |
| 2021 | 5 | 458 | 472 | $837,965 | $62,166 |
| 2020 | 4 | 528 | 569 | $1.1M | $74,954 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 144 | 156 | $317,652 | $20,216 | 6.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 101 | 104 | $142,793 | $8,904 | 6.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 35 | $91,600 | $5,662 | 6.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 103 | 113 | $11,487 | $668.26 | 5.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 160 | 169 | $339,511 | $24,700 | 7.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 80 | 85 | $113,345 | $7,872 | 6.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 33 | 33 | $83,670 | $6,215 | 7.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 46 | 49 | $33,684 | $2,578 | 7.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 105 | 116 | $11,679 | $712.61 | 6.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 236 | 244 | $493,759 | $37,936 | 7.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 68 | 69 | $182,605 | $14,011 | 7.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 94 | 96 | $131,530 | $8,198 | 6.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 37 | 39 | $27,823 | $1,874 | 6.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 23 | 24 | $2,248 | $147.43 | 6.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 293 | 319 | $662,803 | $44,568 | 6.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 98 | 105 | $282,450 | $19,620 | 6.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 91 | 93 | $129,055 | $8,295 | 6.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 46 | 52 | $38,810 | $2,471 | 6.4% |
About Dr. Brian Meyer, MD
Dr. Brian Meyer, MD is a Emergency Medicine healthcare provider based in Jacksonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386697480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Meyer, MD has received a total of $14,821 in payments from pharmaceutical and medical device companies, with $3,486 received in 2023. These payments were reported across 24 transactions from 1 company. The most common payment nature is "Consulting Fee" ($11,335).
As a Medicare-enrolled provider, Meyer has provided services to 1,790 Medicare beneficiaries, totaling 1,901 services with total Medicare billing of $214,647. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Jacksonville, AR
- Active Since 05/18/2006
- Last Updated 08/24/2010
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386697480
Products in Payments
- GILENYA (Drug) $11,335
- MAYZENT (Drug) $3,486
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Jacksonville
Dr. Robert Luten, M.d, M.D
Emergency Medicine — Payments: $278,828
Dr. Arin Piramzadian, D.o, D.O
Emergency Medicine — Payments: $100,431
Daniel D'amore, M.d, M.D
Emergency Medicine — Payments: $44,473
Dr. Joseph Shiber, Md, MD
Emergency Medicine — Payments: $9,760
Petra Duran-Gehring, Md, MD
Emergency Medicine — Payments: $9,053
Michael Lusko, D.o, D.O
Emergency Medicine — Payments: $6,109